Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07781956 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07781956 · ClinicalTrials.gov record · last posted 2026-08-24

Home-Based Supportive Care Program for NMIBC Patients Receiving Intravesical Perfusion: Construction and Preliminary Application

Study acronym: NMIBC-HSC
StatusNot Yet Recruiting
PhaseNot applicable
Started2026-08
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This study focuses on patients with non-muscle-invasive bladder cancer who receive intravesical perfusion therapy. Outpatient perfusion treatment is usually short-term and procedure-oriented, so patients often lack continuous, comprehensive support after returning home, and may face physical discomfort, psychological stress and unmet self-management needs during home recovery. This study aims to identify real-world difficulties and needs of patients in home-based recovery, construct a personalized home supportive care program covering physical symptom relief, psychological support and disease management education, and test its preliminary application effect. It is expected to reduce patients' treatment-related discomfort, improve treatment adherence, and enhance their quality of life.
Trial Details
NCT Number NCT07781956
Lead Sponsor Nanjing First Hospital, Nanjing Medical University
Conditions Non-Muscle-Invasive Bladder Cancer (NMIBC)
Enrollment 40 participants
Start Date 2026-08
Primary Completion 2027-09 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-24